Literature DB >> 4514633

Antigen solubilized from human solid tumours: lymphocyte stimulation and cutaneous delayed hypersensitivity.

G M Mavligit, U Ambus, J U Gutterman, E M Hersh, C M McBride.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4514633     DOI： 10.1038/newbio243188a0

Source DB:  PubMed          Journal:  Nat New Biol        ISSN： 0090-0028


× No keyword cloud information.
  8 in total

1.  Macrophage electrophoretic mobility (MEM) test in malignant gynaecological diseases.

Authors:  H L Jenssen; H Köhler; J Günther; B Klausch; W Straube; R Hofmann; H H Büttner
Journal:  Arch Gynakol       Date:  1976-03-05

2.  Stimulation of peripheral blood lymphocytes with autologous tumor and serum-derived fractions from patients with laryngeal carcinomas.

Authors:  P Koldovsky; U Koldovsky; J Ebbers; K H Vosteen
Journal:  Arch Otorhinolaryngol       Date:  1986

3.  Immunotherapy: its possible application in the management of large-bowel cancer.

Authors:  G M Mavligit; J U Guttermann; M A Burgess; J F Speer; R C Reed; R C Martin; C M McBride; E M Copeland; E A Gehan; E M Hersh
Journal:  Am J Dig Dis       Date:  1974-11

Review 4.  Tumour immunology and the gut.

Authors:  K C Calman
Journal:  Gut       Date:  1975-06       Impact factor: 23.059

Review 5.  Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.

Authors:  A P Zbar; N R Lemoine; M Wadhwa; H Thomas; D Snary; W A Kmiot
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

6.  The use of immunoadsorbent columns for the isolation of antibodies specific for antigens associated with human bronchogenic carcinoma.

Authors:  R D Watson; A G Smith; J G Levy
Journal:  Br J Cancer       Date:  1974-03       Impact factor: 7.640

7.  Tumour antigenicity in ovarian cancer.

Authors:  L Levin; J E McHardy; O M Curling; C N Hudson
Journal:  Br J Cancer       Date:  1975-08       Impact factor: 7.640

8.  Immune response to chemically induced tumours: correlation of responding cell class with in vivo inhibition of tumour growth.

Authors:  M B Calderwood; J T Forbes; R T Smith
Journal:  Br J Cancer       Date:  1981-04       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.